Last checked at 11 Feb 2020 07:00
Creo Medical Group plc
("Creo" or the "Company")
Video abstracts featuring Speedboat procedures in India
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that the Company's Speedboat device has featured in two newly published video abstracts published by clinicians from the Asian Institute of Gastroenterology, Hyderabad, India.
Both video abstracts were authored by experts in the field of Gastrointestinal ("GI") therapeutic endoscopy for the Asian Institute of Gastroenterology, Hyderabad, India. These procedures follow on from the first in-human use of the Speedboat device in India as announced in November last year, as well as additional procedures in multiple sites in the US, UK, Spain, South Africa and, more recently, Australia.
The first video abstract, published on Video GIE, the official video journal of the American Society of Gastrointestinal Endoscopy, is titled, "Peroral endoscopic myotomy in a patient with failed Heller's myotomy by use of a novel bipolar radiofrequency device." The abstract can be viewed on:
https://www.videogie.org/article/S2468-4481(19)30344-3/fulltext
The second video abstract, published via an open access content publisher, Thieme Group, is titled, "Endoscopic dissection of an esophageal submucosal tumor using a novel bipolar radiofrequency device" and can be viewed online here: https://www.thieme-connect.de/products/ejournals/html/10.1055/a-1089-7680
Craig Gulliford, Chief Executive Officer, commented: "We are delighted to see physicians from different parts of the world not only treating patients but quickly getting published in video form which really highlights the power of advanced energy in the flexible endoscopy setting. Particularly impressive is the size of blood vessels which are being managed with ease using microwave energy and our Speedboat where traditional technology would have struggled even with multiple devices being deployed."
Creo Medical Group plc | investors.creomedical.com |
Richard Rees (CFO) | +44 (0)1291 606 005 |
|
|
Cenkos Securities | +44 (0)20 7397 8900 |
Stephen Keys / Cameron MacRitchie (NOMAD) |
|
Michael Johnson / Russell Kerr (Sales) |
|
|
|
Walbrook PR Ltd | Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com |
Paul McManus / Lianne Cawthorne | Mob: +44 (0)7980 541 893 / +44 (0)7515 909 238 |
About Creo Medical
Creo Medical, founded in 2003, is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and RF energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical Advanced Energy Platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides clinicians with flexible, accurate and controlled surgical solutions.
The Company's strategy is to bring its CROMA Advanced Energy Platform powered by unique full spectrum adaptive technology to market enabling a suite of medical devices which the Company has designed, initially for the emerging field of GI therapeutic endoscopy, an area with high unmet needs. The CROMA Advanced Energy platform will be developed further for bronchoscopy and laparoscopy procedures. The Company believes its technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option of treatment.
For more information about Creo Medical please see our website, investors.creomedical.com